U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
143251143251Fed Bioavailability Study of Zonisamide CapsulesCompletedHas ResultsHealthyDrug: Zonisamide 100 mg Capsule|Drug: Zonisamide (Zonegran®) 100 mg Capsulehttps://ClinicalTrials.gov/show/NCT00687167
143252143252Observational Study of DME Following Scatter Laser PhotocoagulationCompletedNo Results AvailableDiabetic Macular EdemaProcedure: Scatter Laser Photocoagulation in 1 Sitting|Procedure: Scatter Laser Photocoagulation in 4 Sittingshttps://ClinicalTrials.gov/show/NCT00687154
143253143253Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy SubjectsCompletedNo Results AvailableAlzheimer's DiseaseDrug: AZD0328|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00687141
143254143254Exercise Dose-Response on Features of the Metabolic SyndromeCompletedNo Results AvailableInsulin Resistance|Metabolic Syndrome|ObesityBehavioral: Low-intensity treadmill exercise|Behavioral: Moderate-intensity treadmill exercise|Behavioral: Non-aerobic stretching exercisehttps://ClinicalTrials.gov/show/NCT00687128
143255143255Predicting Weight Gain and Weight Loss Associated With Overeating or FastingRecruitingNo Results AvailableObesity|Diet Therapy|Weight Loss|Weight Gain|Nutrition TherapyBehavioral: Weight Loss|Behavioral: Overfeeding|Behavioral: Overfeeding Low Prohttps://ClinicalTrials.gov/show/NCT00687115
143256143256Cognition in the Study of Tamoxifen and RaloxifeneCompletedNo Results AvailableCognition|AgingDrug: tamoxifen|Drug: raloxifenehttps://ClinicalTrials.gov/show/NCT00687102
143257143257Examination of Cognitive Function in Patients Treated With SubutexCompletedNo Results AvailableOpiate AddictionOther: Sexual, cognitive functional tests and measurement weighthttps://ClinicalTrials.gov/show/NCT00687089
143258143258Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)CompletedHas ResultsPeripheral Arterial DiseaseDrug: Ezetimibe|Drug: Niaspan|Drug: Statin therapy|Behavioral: Standard care|Drug: Aspirin|Drug: Clopidogrel|Drug: Placebo Niaspan|Drug: Placebo Ezetimibe|Procedure: Percutaneous transluminal angioplasty (PTA)https://ClinicalTrials.gov/show/NCT00687076
143259143259Observational Study of Safety and Efficacy of Levemir® in Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin detemirhttps://ClinicalTrials.gov/show/NCT00687063
143260143260Peroral Supplemental Nutrition in End-stage Renal Disease With and Without HIV ComorbidityCompletedNo Results AvailableEnd-Stage Renal DiseaseDietary Supplement: peroral high-caloric supplemental nutrition|Dietary Supplement: peroral supplemental nutritionhttps://ClinicalTrials.gov/show/NCT00687050
143261143261Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela PowerCompletedNo Results AvailableHealthyDrug: Cetylpyridinium chloridehttps://ClinicalTrials.gov/show/NCT00687037
143262143262Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical DysplasiaCompletedNo Results AvailableFocal Cortical Dysplasia|EpilepsyProcedure: Magnetoencephalography|Procedure: MR imaging|Procedure: Diffusion Tensor Imaginghttps://ClinicalTrials.gov/show/NCT00687024
143263143263Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)CompletedNo Results AvailableNeoplasms|Nausea|VomitingDrug: Palonosetron and Dexamethasonehttps://ClinicalTrials.gov/show/NCT00687011
143264143264Phase IIA Study in Patients With SchizophreniaCompletedHas ResultsSchizophreniaDrug: AZD2624|Drug: Olanzapine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00686998
143265143265Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung CancerRecruitingNo Results AvailableSmall Cell Lung CancerDrug: Carboplatin, docetaxelhttps://ClinicalTrials.gov/show/NCT00686985
143266143266The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body CompositionActive, not recruitingNo Results AvailableBariatric SurgeryDrug: GLP-1https://ClinicalTrials.gov/show/NCT00686972
143267143267Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung CancerCompletedNo Results AvailableNon Small Cell Lung CancerDrug: Pemetrexed|Drug: Cisplatin|Drug: Etoposide|Drug: Cisplatin|Drug: Vinorelbine|Drug: Paclitaxel|Drug: Carboplatin|Radiation: Thoracic Radiation Therapy (TRT)|Radiation: Thoracic Radiation Therapy (TRT)https://ClinicalTrials.gov/show/NCT00686959
143268143268The National Register of Antipsychotic Medication in Pregnancy (NRAMP)RecruitingNo Results AvailablePregnancy|Mental Disordershttps://ClinicalTrials.gov/show/NCT00686946
143269143269Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNo Results AvailableAttention-Deficit/Hyperactivity DisorderDrug: ABT-089https://ClinicalTrials.gov/show/NCT00686933
143270143270Safety Study for Patients With a History of Hepatic EncephalopathyCompletedNo Results AvailableHepatic EncephalopathyDrug: rifaximinhttps://ClinicalTrials.gov/show/NCT00686920
143271143271Blind Adult Melatonin Treatment StudyActive, not recruitingNo Results AvailableBlindnessDrug: Melatoninhttps://ClinicalTrials.gov/show/NCT00686907
143272143272Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)TerminatedHas ResultsSpondylitis, Ankylosing|(SpA)Procedure: PDUS|Drug: Infliximabhttps://ClinicalTrials.gov/show/NCT00686894
143273143273Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)TerminatedHas ResultsHepatitis C, ChronicBiological: Peginterferon alfa-2b (PegIFN-2b)|Drug: Comparator: Stronger neo minophagen C (SNMC)https://ClinicalTrials.gov/show/NCT00686881
143274143274Study to Evaluate SC Route of Administration of Ofatumumab in RA PatientsCompletedNo Results AvailableArthritis, RheumatoidOther: placebo|Drug: ofatumumabhttps://ClinicalTrials.gov/show/NCT00686868
143275143275Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host DiseaseCompletedHas ResultsOral Chronic Graft-versus-host DiseaseDrug: Tacrolimus|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00686855
143276143276PTC299 in Treating Patients With HIV-Related Kaposi SarcomaTerminatedHas ResultsKaposi's SarcomaDrug: VEGF inhibitor PTC299|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT00686842
143277143277Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)(COMPLETED)CompletedNo Results AvailableHIV InfectionsDrug: Vicriviroc maleatehttps://ClinicalTrials.gov/show/NCT00686829
143278143278Weight Loss in Pre-diabetic, Obese WomenCompletedNo Results AvailableObesityDietary Supplement: Low calorie diet|Dietary Supplement: Olestrahttps://ClinicalTrials.gov/show/NCT00686816
143279143279Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled HypertensionCompletedHas ResultsHypertensionDrug: PL3994|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00686803
143280143280Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)CompletedHas ResultsHepatitis D, Chronic|Hepatitis B, ChronicBiological: Peginterferon alfa-2b (PegIntron, SCH 54031)https://ClinicalTrials.gov/show/NCT00686790

* Görseller ve İçerik tekif hakkına sahip olabilir